Standard BioTools Inc experienced a rather steady stock market performance. The highest value in the past year was recorded at $3.16 on 09/01/23 and the lowest value was $1.57 on 10/16/23.
52-week price history of LAB Stock
Studying a stock’s 52-week price history, which includes both low and high prices, can help gauge its current status and potential future performance. Standard BioTools Inc’s current trading price is -21.84% away from its 52-week high, while its distance from the 52-week low is 57.32%. The stock’s price range during the 52-week period has remained between $1.57 and $3.16. In the Healthcare sector, the company’s shares saw a trading volume of around 1.38 million for the day, which was evidently lower than the average daily volume of 2.31 million over the past three months.
Market Capitalization and Financial Performance: An In-Depth Look
Standard BioTools Inc (LAB) has experienced a quarterly rise of 4.66% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 946.13M and boasts a workforce of 539 employees.
Making Sense of Trading Volume and Moving Average Data
Based on Barchart.com data, the company’s moving average over the 100-day period was 2.43, with a change in price of +0.25. Similarly, Standard BioTools Inc recorded 2,105,358 in trading volume during the last 100 days, posting a change of +11.36%.
Examining LAB’s Debt-to-Equity Ratio: What You Need to Know
The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for LAB stands at 0.16. Similarly, the long-term debt-to-equity ratio is also 0.05.
LAB Stock Stochastic Average
As of today, Standard BioTools Inc’s raw stochastic average for the last 50 days stands at 32.18%. This is a decline compared to the raw stochastic average of the previous 20 days, which was noted at 36.36%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 23.81% and 26.98%, respectively.
LAB Stock Price Performance Analysis
Investors have been left with mixed emotions regarding the stock price performance over the year, as it’s been a mixed bag. The index has shown a price gain of 11.76% this year. Over the last six months, there has been a weaker performance of 24.12%. The price of LAB leaped by -13.03% during the last 30 days period. For the last 5-days stocks have slided -2.37%.
